Stock Price Quote

FORTIS HEALTHCARE LTD.

NSE : FORTISBSE : 532843ISIN CODE : INE061F01013Industry : Hospital & Healthcare ServicesHouse : Fortis
BSE486.35-1.9 (-0.39 %)
PREV CLOSE ( ) 488.25
OPEN PRICE ( ) 484.05
BID PRICE (QTY) 486.15 (2)
OFFER PRICE (QTY) 486.75 (52)
VOLUME 36112
TODAY'S LOW / HIGH ( )483.45 499.60
52 WK LOW / HIGH ( )298 509.85
NSE486.45-1.3 (-0.27 %)
PREV CLOSE( ) 487.75
OPEN PRICE ( ) 489.20
BID PRICE (QTY) 486.10 (27)
OFFER PRICE (QTY) 486.55 (57)
VOLUME 867089
TODAY'S LOW / HIGH( ) 483.35 499.95
52 WK LOW / HIGH ( )298.45 509.85
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-02 1996
Management Info
Ravi Rajagopal - Chairman Ashutosh Raghuvanshi - Managing Director
Registered Office

Address Fortis Hospital, Sector 62,Phase – Viii, ,
Mohali,
Punjab-160062

Phone 0172-5096001

Email secretarial@fortishealthcare.com

Website www.fortishealthcare.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX

NEWS

24May Fortis Healthcare reports 47% rise in
Fortis Healthcare has reported results for fourth quarter (Q4) and year..
23Feb Fortis Healthcare informs about disclo
In terms of Regulation 30(4) of SEBI Listing Regulations read with SEBI..
02Feb Fortis Healthcare’s arm sells business
Fortis Healthcare’s listed subsidiary -- Fortis Malar Hospitals has sold..
13Nov Fortis Healthcare reports 16% fall in
Fortis Healthcare has reported results for second quarter ended Septembe..
30Sep Fortis Healthcare informs about disclo
In continuation to the intimation dated August 4, 2023 in relation to in..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit683.31994.5
Gross Profit 896.1 2465.6
Operating Profit 10183358.1
Net Sales 3074.811814.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kovai Medical Center (BSE)
peergroup  4241.00 (2.66%)
M.Cap ( in Cr)4593.56
Kaya (BSE)
peergroup  473.35 (9.99%)
M.Cap ( in Cr)618.39
Yatharth Hospital (BSE)
peergroup  421.15 (0.56%)
M.Cap ( in Cr)3639.62
Tejnaksh Healthcare (BSE)
peergroup  24.53 (1.07%)
M.Cap ( in Cr)50.32
Aspira Pathlab&Diagn (BSE)
peergroup  29.14 (0.55%)
M.Cap ( in Cr)29.34

Shareholding Pattern

FI/BANKS/INSURANCE 4.51%
PROMOTERS 31.17%
MUTUAL FUNDS/UTI 26.51%
NON-INSTITUTION 14.45%
GOVERNMENT 0%
FII 0%

About

no data found

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.